Ropinirole recalls

The FDA has published 13 recalls involving Ropinirole since 2013. The latest was reported on 12 Apr 2023. Most were for manufacturing (cgmp) deviations. Accord Healthcare has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls13since 2013
Last 12 months0reported
Class I00% of total
Ongoing0latest 12 Apr 2023

Recalls per month, last 24 months

click a bar for that month

Severity split

Class I 0 0%Class II 13 100%Class III 0 0%

By year

All ropinirole recalls, newest first

13 total
ReportedClassRecallCompanyReasonWhere
DrugCLASS IIRopinirole 0.5 mg tablets, packaged in 90-count bottles, Rx only recalledRemedyRepackManufacturing (CGMP) DeviationsNationwide
DrugCLASS IIRopinirole 2mg tablets recalled by RemedyRepackRemedyRepackManufacturing (CGMP) DeviationsNationwide
DrugCLASS IIRopinirole recalled by Direct RxDirect RxManufacturing (CGMP) DeviationsNationwide
DrugCLASS IIRopinirole recalled by Direct RxDirect RxManufacturing (CGMP) DeviationsNationwide
DrugCLASS IIrOPINIRole Tablets USP 0.5 mg* recalled by Accord HealthcareRopiniroleAccord HealthcareManufacturing (CGMP) DeviationsPR
DrugCLASS IIrOPINIRole Tablets USP 4 mg* recalled by Accord HealthcareRopiniroleAccord HealthcareManufacturing (CGMP) DeviationsPR
DrugCLASS IIrOPINIRole Tablets USP 1 mg* recalled by Accord HealthcareRopiniroleAccord HealthcareManufacturing (CGMP) DeviationsPR
DrugCLASS IIrOPINIRole Tablets USP 3 mg* recalled by Accord HealthcareRopiniroleAccord HealthcareManufacturing (CGMP) DeviationsPR
DrugCLASS IIrOPINIRole Tablets USP 5 mg* recalled by Accord HealthcareRopiniroleAccord HealthcareManufacturing (CGMP) DeviationsPR
DrugCLASS IIrOPINIRole Tablets USP 2 mg* recalled by Accord HealthcareRopiniroleAccord HealthcareManufacturing (CGMP) DeviationsPR
DrugCLASS IIrOPINIRole Tablets USP 0.25 mg* recalled by Accord HealthcareRopiniroleAccord HealthcareManufacturing (CGMP) DeviationsPR
DrugCLASS IIRopinirole, extended-release tablets, 2 mg recalled by SandozSandozOtherNationwide
DrugCLASS IIRopinirole hydrochloride tablets, USP 4 mg bottle recalledMylan PharmaceuticalsLabeling ErrorsNationwide

Should you stop taking Ropinirole?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.